Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding IGM Biosciences, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IGMS: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7966−13
Shares17.8M15.9M−1.86M (−10.5%)
Value$20.5M$17.9M−$2.62M (−12.8%)

New holders (10)

Institutions that held IGM Biosciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IGMS in Q2 2025
InstitutionSharesValue% of portfolio
Millennium Management LLC275,112$308.1K0.00%
Jane Street Group, LLC180,985$202.7K0.00%
Marshall Wace, LLP44,287$49.6K0.00%
XTX Topco Ltd26,472$29.6K0.00%
SG Americas Securities, LLC15,304$17.0K0.00%
Ground Swell Capital, LLC11,833$13.3K0.02%
Point72 Asia (Singapore) Pte. Ltd.11,133$12.5K0.00%
Raymond James Financial Inc1,325$1.48K0.00%
Clearstead Advisors, LLC61$690.00%
Essential Partners LLC16$180.00%

Sold out (23)

Institutions that held IGM Biosciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.